Free Trial

ECO Animal Health Group (LON:EAH) Stock Price Crosses Below 50 Day Moving Average - What's Next?

ECO Animal Health Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell below the 50‑day moving average, trading as low as GBX 87.48 and last at GBX 93.76 versus a 50‑day MA of GBX 100.92 on volume of 591,666 shares.
  • Analyst stance remains positive: Shore Capital reaffirmed a "Buy" and the consensus rating is Buy with an average target price of GBX 160.
  • The company has a market cap of £63.4m and a P/E of 21.53, with strong liquidity (current ratio 3.73, quick ratio 2.14) but a high debt‑to‑equity of 5.97.
  • Five stocks we like better than ECO Animal Health Group.

ECO Animal Health Group plc (LON:EAH - Get Free Report) shares passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 100.92 and traded as low as GBX 87.48. ECO Animal Health Group shares last traded at GBX 93.76, with a volume of 591,666 shares trading hands.

Analyst Ratings Changes

Separately, Shore Capital Group reaffirmed a "buy" rating on shares of ECO Animal Health Group in a research report on Wednesday, March 11th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of GBX 160.

View Our Latest Stock Report on ECO Animal Health Group

ECO Animal Health Group Price Performance

The stock has a market cap of £63.40 million, a P/E ratio of 21.53 and a beta of 0.05. The company has a 50 day simple moving average of GBX 100.92 and a 200 day simple moving average of GBX 98.48. The company has a current ratio of 3.73, a quick ratio of 2.14 and a debt-to-equity ratio of 5.97.

ECO Animal Health Group Company Profile

(Get Free Report)

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ECO Animal Health Group Right Now?

Before you consider ECO Animal Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ECO Animal Health Group wasn't on the list.

While ECO Animal Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines